3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
22
Osteoporosis
4
Obesity
2
Bone Diseases
2
Vitamin D Deficiency
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Pain
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Lung Neoplasms
1
Heart Diseases
1
Coronary Disease
1
Colonic Neoplasms
1
Chemotherapy-Related Cognitive Impairment
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Biomarker Change Linked to Breast Cancer
1
Interventions
Paclitaxel
3
Acupuncture Therapy
3
Glutamine
2
Fatty Acids, Omega-3
2
Cryotherapy
2
eribulin
1
Yoga
1
Vitamin D
1
Vitamin B 6
1
Vitamin B 12
1
Thioctic Acid
1
Taxoids
1
Surveys and Questionnaires
1
Sugars
1
Sodium Chloride
1
Silymarin
1
Saline Solution
1
Physical Therapy Modalities
1
Pentoxifylline
1
Omacor
1
Minocycline
1
Methods
1
Metformin
1
Massage
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Lidocaine
1
Hydroxychloroquine
1
Fumigant 93
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Vitamin D
×
Breast
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled